No results for ‘’
Metropolis Healthcare Ltd
₹567.95
(1.41%)
Sat, 11 Jul 2026, 06:44 am
Health Services
Medical/Nursing Services
24.5KMetropolis Healthcare Price to Sales Ratio (P/S)
| Particulars | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 0 | 0 | 0 | 50.95 | 62.62 | 48.89 | 44.90 | 69.42 | 55.50 |
| Price to book ratio | 0 | 0 | 0 | 0 | 0 | 0 | 12.44 | 16.21 | 11.76 | 6.47 | 8.07 | 6.08 |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | 0 | 7.58 | 11.49 | 8.52 | 5.59 | 7.35 | 6.04 |
| Price to cash flow ratio | 0 | 0 | 0 | 0 | 0 | 0 | 29.67 | 44.19 | 40.84 | 26.42 | 33.82 | 30.45 |
| Enterprise value | 0 | 0 | 0 | 0 | 0 | 0 | 6332Cr | 11151Cr | 10671Cr | 6578Cr | 8949Cr | 8136Cr |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 0 | 0 | 0 | 29.13 | 37.47 | 29.73 | 21.70 | 29.83 | 25.92 |
| Debt to equity ratio | 0.07 | 0.04 | 0.02 | 0 | 0 | 0.04 | 0.13 | 0.16 | 0.43 | 0.27 | 0.18 | 0.15 |
| Return on equity % | 0 | 18.36 | 23.98 | 33.78 | 28.25 | 28.84 | 27.03 | 29.77 | 26.89 | 15.25 | 12.26 | 11.95 |
Metropolis Healthcare Ltd Price to Sales Ratio
The Metropolis Healthcare Ltd Price to Sales Ratio is a key financial metric used by investors to evaluate Metropolis Healthcare Ltd's valuation, profitability, and overall financial performance. Tracking the Metropolis Healthcare Ltd Price to Sales Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Metropolis Healthcare Ltd (NSE: METROPOLIS, BSE: 542650) is currently trading at ₹567.95, with a market capitalization of ₹11612.66Cr. As a leading company in the Health services sector and Medical/Nursing services industry, monitoring the Metropolis Healthcare Ltd Price to Sales Ratio is essential for fundamental analysis.
Metropolis Healthcare Ltd Price to Sales Ratio Current Value
The current Metropolis Healthcare Ltd Price to Sales Ratio stands at 6.04.
The Metropolis Healthcare Ltd Price to Sales Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Metropolis Healthcare Ltd Price to Sales Ratio Historical Trend
The Metropolis Healthcare Ltd Price to Sales Ratio has shown the following historical trend:
- 2024: 6.04
- 2023: 7.35
- 2022: 5.59
- 2021: 8.52
- 2020: 11.49
The decline in Metropolis Healthcare Ltd Price to Sales Ratio indicates improving financial efficiency or better earnings growth.
What Metropolis Healthcare Ltd Price to Sales Ratio Indicates for Investors
The Metropolis Healthcare Ltd Price to Sales Ratio plays a crucial role in understanding the company's financial health and valuation.
The P/S ratio helps evaluate valuation relative to company revenue.
Metropolis Healthcare Ltd Price to Sales Ratio Analysis Summary
The Metropolis Healthcare Ltd Price to Sales Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Metropolis Healthcare Ltd Price to Sales Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Metropolis Healthcare Ltd Price to Sales Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.